David Wilson

CNS pipeline · person

David Wilson

Non-Executive Director of Neuphoria Therapeutics (formerly Bionomics) since June 2016. Chairman and founding partner of WG Partners LLP, a life-sciences investment banking boutique, since 2011; he previously served as CEO of European Operations and Chairman of the Global Healthcare Team at Piper Jaffray. He received his Bachelor's degree from the University of Cambridge.

  • 1 company

Courtesy Neuphoria Therapeutics

Current roles

Appears with

People sharing a company with David.

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.